---
title: Friedberg JW, Bordoni R, Patel-Donnelly D, etÂ al. Brentuximab vedotin with
  dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible
  for chemotherapy. Blood. 2024;143(9):786-795
date: '2024-10-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39388158/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241011200419&v=2.18.0.post9+e462414
source: Blood
description: No ...
disable_comments: true
---
No ...